Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study - Schjesvold, Fredrik H; Ludwig, Heinz; Delimpasi, Sossana; Robak, Pawel; Coriu, Daniel; Tomczak, Waldemar; Pour, Ludek; Spicka, Ivan; Dimopoulos, Meletios-Athanasios; Masszi, Tamas; Chernova, Natalia G; Sandberg, Anna; et al. (Haematologica, 2024)
Keywords: Neoplasm Recurrence, Local; Drug Resistance, Neoplasm; Phenylalanine; recidiva; kvalita života; senioři; Aged; Male; Dexamethasone; lidé; Treatment Outcome; lidé středního věku; Humans; Antineoplastic Combined Chemotherapy Protocols; Multiple Myeloma; Middle Aged; Quality of Life; chemorezistence; protokoly protinádorové kombinované chemoterapie; dexamethason; lokální recidiva nádoru; mnohočetný myelom; mužské pohlaví; výsledek terapie; fenylalanin; Recurrence; ženské pohlaví; Female